← All organizations

COD Research Private Ltd

For profit

Also known as: COD Research Private Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 15, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

omalizumab

Phase 2 (1 own, 0 via acquisition)

curcuma longa

Recent trials (2)

NCT05774639CollaboratorPhase 3Aug 15, 2023
NCT06256926Lead sponsorPhase 2Jan 8, 2021

Details

Last known activity: Aug 15, 2023